An update from infectious disease expert, Rana F. Hamdy, MD, on the Omicron variant of COVID-19.
On November 26, 2021, the World Health Organization (WHO) designated the B.1.1.529 variant a variant of concern (VOC), and assigned its name the Greek letter Omicron.
The B.1.1.529 variant, which was first reported to the WHO from South Africa on November 24, 2021, contains around 50 mutations, of which more than 30 are in the spike protein of the SARS-CoV-2 virus. These include some of the mutations also found in the Delta and Alpha variants which have been linked to increased transmissibility.
A sharp rise in cases of SARS-CoV-2 over the last 2 weeks of November 2021 in South Africa, specifically in the Gauteng province, raise concern because of 1)the rapidity with which number of daily cases is increasing is a faster rate than with any of the past 3 waves experienced in South Africa, and 2)the rapidity with which the B.1.1.529 variant took to represent the majority of SARS-CoV-2 cases (accounting for 90% of SARS-CoV-2 cases in just 2 weeks, compared to the 3 months it took for the Delta variant to become the predominant variant during the previous wave). These epidemiologic data support the concern for increased transmissibility of this variant compared to previous VOCs.
As of November 30, the Omicron variant has been detected in 19 countries around the world. As of the morning of November 30, it had not yet been detected in the United States. Studies are underway to understand if this variant is associated with a different severity of disease compared to other SARS-CoV-2 variants. Anecdotes from clinicians in South Africa do not suggest increased severity of disease, but additional information is needed.
Studies are also underway to understand the effectiveness of current vaccines in protecting against the Omicron variant. The mutations in the B.1.1.529 variant are not impacted by the currently used PCR test, so ability to detect infection with this variant are not expected to be impacted.
References
1. World Health Organization, News. Accessed November 30, 2021, Available at: https://www.who.int/news/item/26-11-2021-classification-of-omicron-(b.1.1.529)-sars-cov-2-variant-of-concern
2. Nature News. 25 November 2021. Heavily mutated Omicron variant puts scientists on alert. Accessed November 30, 2021. Available at: https://www.nature.com/articles/d41586-021-03552-w
3. COVID-19 Statistics for Republic of South Africa. National Institute for Communicable Diseases. Latest Confirmed Cases of COVID-19 in South Africa (30 November 2021). Available at: https://www.nicd.ac.za/latest-confirmed-cases-of-covid-19-in-south-africa-30-november-2021/
This article was originally published on Contemporary Pediatrics®.
Contemporary OB/GYN Senior Editor Angie DeRosa gets insight on the current state of COVID-19 from Christina Han, MD, division director of maternal-fetal medicine at the University of California, Los Angeles, and member of its COVID-19 task force. Han is an active member of the Society for Maternal-Fetal Medicine and discusses the issues on behalf of SMFM.
Listen
NAID report shows maternal COVID-19 vaccination protects newborns
April 4th 2024New research led by the National Institute of Allergy and Infectious Diseases reveals sustained antibody levels in infants born to vaccinated mothers, underscoring the importance of maternal vaccination in safeguarding newborns against COVID-19.
Read More
Decreased adolescent pregnancy and sexual health care during COVID-19 pandemic
February 13th 2024Adolescent pregnancy and sexual health care utilization declined during the COVID-19 pandemic, indicating significant disruptions in reproductive health services for young females, as highlighted in a recent study published in Pediatrics.
Read More
COVID-19 vaccination during pregnancy not linked to preterm birth
January 31st 2024A systematic review of 6 studies revealed that COVID-19 vaccination during pregnancy does not significantly increase the risk of preterm birth, providing crucial insights for public health policies and offering reassurance to healthcare providers and expectant mothers.
Read More